Business
Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering
Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of $500 million in aggregate principal amount of 5.875% senior notes due 2034 (the "Notes") at a price of 100% of the principal amount thereof. The Company will pay interest on the Notes semiannually in arrears on June 1 and Dec. 1 of each year, beginning on Dec. 1, 2026. The Notes will be jointly and severally guaranteed on a senior unsecured basis by all of its existing and future subsidiaries that guarantee b
About this update from Encompass Health Corporation
[{"type":"text","content":"BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of $500 million in aggregate principal amount of 5.875% senior notes due 2034 (the "Notes") at a price of 100% of the principal amount thereof. The Company will pay interest on the Notes semiannually in arrears on June 1 and Dec. 1 of each year, beginning on Dec. 1, 2026. The Notes will be jointly and severally guaranteed on a senior unsecured basis by all of its existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt. This offering is expected to close on May 29, 2026, subject to customary closing conditions.","length":757,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Encompass Health Corporation)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Encompass Health Corporation)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":152,"url":"https://media.zenfs.com/en/prnewswire.com/a7ce07e830d1e0fee63e778bf4a8b83c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/P1TrdTQNuJr_fE809Ttb5g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI2OA--/https://media.zenfs.com/en/prnewswire.com/a7ce07e830d1e0fee63e778bf4a8b83c","width":400,"height":152},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/RosPLZ.08puxu8y.4NbpaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTI0Mw--/https://media.zenfs.com/en/prnewswire.com/a7ce07e830d1e0fee63e778bf4a8b83c","width":400,"height":152}},"href":"https://mma.prnewswire.com/media/619202/Encompass_Health_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Company intends to use the net proceeds from this offering, together with available cash on hand, to redeem at par $400 million in aggregate principal amount of its outstanding 4.500% Senior Notes due 2028, to repay $100 million of the outstanding amounts under the Company's senior secured revolving credit facility and to pay certain related fees and expenses in connection with the foregoing.","length":403,"tagName":"p"},{"type":"text","content":"The Notes have been offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act&q...